SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
581CIMZIA(TM) Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis Thurnigel bates-6/14/2007
580April 26, 2006 The deal gives Isotechnika (TSX:ISA) the option to obtain an exclteevee-6/8/2007
579Isotechnika receives approval from Polish competent authority for pivotal Phase teevee-6/6/2007
578phase 3 psoriasis trial underway: clinicaltrials.govteevee-5/22/2007
577NEW YORK, May 22 (Reuters) - Celgene Corp. (CELG.O: Quote, Profile , Research) ssim1-5/22/2007
576[Roche/Chugai, anti-IL-6R] Roche's Actemra similar to other RA drugs in stuscaram(o)uche-5/14/2007
575Laquinimod data presented at scientific meeting (AAN) Active Biotech (SEK79.75Icebrg-5/3/2007
574Name Company Delivery Mechanism Mechanism of Action Phase Indication ABT-874 Abbsoftware salesperson-4/4/2007
573Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis Friday Febnigel bates-2/23/2007
572Biovitrum and Synphora Initiate Phase II Study of Psoriasis Treatment Monday Febnigel bates-2/5/2007
5711:06PM Genentech announces <b>"positive results" from a Phase IVIan@SI-2/2/2007
570Proc Natl Acad Sci U S A. 2007 Jan 30; [Epub ahead of print] Substance P mediatscaram(o)uche-2/1/2007
569Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate Significant Improvscaram(o)uche-1/24/2007
568Biotech Psoriasis Drugs Hit a Cost Ceiling By ANDREW POLLACK Are biotechnology Icebrg-1/24/2007
567Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate Significant Improvnigel bates-1/24/2007
566MediGene Initiates a Clinical Phase IIa Trial of RhuDex® in Rheumatoid Arthnigel bates-1/23/2007
565Arthritis, rheumatism cost U.S. $128B By DANIEL YEE, Associated Press Writer Frscaram(o)uche-1/12/2007
564Phytomedics' Novel Oral Disease Modifying Drug Candidate PMI-001 Demonstratenigel bates-11/28/2006
563PI3Kbig gamma inhibition: towards an 'aspirin of the 21st century'? Thotnsaf-11/24/2006
562New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Ratesnigel bates-11/13/2006
561coooooooooool! thanks.scaram(o)uche-10/25/2006
5601: Mol Immunol. 2006 Sep 23; [Epub ahead of print] Links A humanized monoclonakeokalani'nui-10/25/2006
559Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) in TreLJM-10/20/2006
558J Leukoc Biol. 2006 Oct 13; [Epub ahead of print] Transcriptional regulation scaram(o)uche-10/19/2006
557msnbc.msn.com Interesting connection to heart issues.Arthur Radley-10/10/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News